Ani Arakelian
Montreal, QC H4A3J1, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Methyl-CpG binding domain protein 2 (Mbd2) drives breast cancer progression through the modulation of epithelial-to-mesenchymal transition.
Journal: Experimental & molecular medicine
Published: December 04, 2022
S-adenosylmethionine blocks tumorigenesis and with immune checkpoint inhibitor enhances anti-cancer efficacy against BRAF mutant and wildtype melanomas.
Journal: Neoplasia (New York, N.Y.)
Published: November 01, 2022
Identification of an Epigenetic Signature of Osteoporosis in Blood DNA of Postmenopausal Women.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: June 10, 2021
Enhanced Anticancer Effect of a Combination of S-adenosylmethionine (SAM) and Immune Checkpoint Inhibitor (ICPi) in a Syngeneic Mouse Model of Advanced Melanoma.
Journal: Frontiers in oncology
Published: March 23, 2020
S-adenosylmethionine in combination with decitabine shows enhanced anti-cancer effects in repressing breast cancer growth and metastasis.
Journal: Journal of cellular and molecular medicine
Published: February 17, 2020
An enhanced chemopreventive effect of methyl donor S-adenosylmethionine in combination with 25-hydroxyvitamin D in blocking mammary tumor growth and metastasis.
Journal: Bone research
Published: November 21, 2019
DNA methylation signatures of Prostate Cancer in peripheral T-cells.
Journal: BMC cancer
Published: July 12, 2019
uPAR antibody (huATN-658) and Zometa reduce breast cancer growth and skeletal lesions.
Journal: Bone research
Published: July 05, 2019
Identification of an Epigenetic Signature of Osteoporosis in Blood DNA of Postmenopausal Women.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: March 01, 2018
DNA methylation signatures of breast cancer in peripheral T-cells.
Journal: BMC cancer
Published: September 06, 2017
Methyl donor S-adenosylmethionine (SAM) supplementation attenuates breast cancer growth, invasion, and metastasis in vivo; therapeutic and chemopreventive applications.
Journal: Oncotarget
Published: August 08, 2017
Last Updated: 09/26/2026